We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+7.26%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.65%
AUM
$174B
AUM Growth
-$6.35B
Cap. Flow
-$18.1B
Cap. Flow %
-10.41%
Top 10 Hldgs %
24.73%
Holding
7,511
New
987
Increased
2,303
Reduced
2,570
Closed
1,209

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$1.09B
2
LRCX icon
Lam Research
LRCX
+$351M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$330M
4
AAPL icon
Apple
AAPL
+$328M
5
BA icon
Boeing
BA
+$292M

Sector Composition

Rank Sector Weight
1 Technology 8.37%
2 Healthcare 7.97%
3 Financials 6.13%
4 Consumer Discretionary 5.62%
5 Industrials 5.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACOR
5351
DELISTED
Acorda Therapeutics
ACOR
$102K ﹤0.01%
8,724
-1,147
-12% -$19.1K
FBRX icon
5352
Forte Biosciences
FBRX
$1.57B
$100K ﹤0.01%
3,949
+1,245
+46% +$31.3K
MTNB icon
5353
Matinas BioPharma
MTNB
$1.76M
$100K ﹤0.01%
4,239
-549
-11% -$13.9K
RBKB icon
5354
Rhinebeck Bancorp
RBKB
$190M
$100K ﹤0.01%
13,120
-1,335
-9% -$12.1K
GRNA
5355
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$100K ﹤0.01%
231,935
+82,461
+55% +$63.3K
JSPR icon
5356
Jasper Therapeutics
JSPR
$22M
$99K ﹤0.01%
5,472
+2,505
+84% +$46.3K
SVIIW
5357
CALL
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$99K ﹤0.01%
520,200
+156,000
+43% +$36.7K
ONCR
5358
DELISTED
Oncorus, Inc.
ONCR
$99K ﹤0.01%
286,667
+10,309
+4% +$3.85K
YELL
5359
DELISTED
Yellow Corporation Common Stock
YELL
$99K ﹤0.01%
48,778
-1,262,787
-96% -$3.37M
KINS icon
5360
Kingstone Companies
KINS
$294M
$98K ﹤0.01%
71,711
-18,330
-20% -$26.9K
CASA
5361
DELISTED
Casa Systems, Inc. Common Stock
CASA
$98K ﹤0.01%
77,559
+57,521
+287% +$175K
AMAM
5362
DELISTED
Ambrx Biopharma Inc
AMAM
$98K ﹤0.01%
10,989
-7,804
-42% -$39.2K
WALDW icon
5363
CALL
Waldencast PLC Warrant
WALDW
$4.74M
$97K ﹤0.01%
162,060
EVTL.WS
5364
CALL
DELISTED
Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share
EVTL.WS
$97K ﹤0.01%
553,489
DYAI icon
5365
Dyadic International
DYAI
$35.3M
$96K ﹤0.01%
53,915
-22,995
-30% -$35K
NYXH
5366
Nyxoah
NYXH
$141M
$96K ﹤0.01%
12,991
+2,215
+21% +$12.4K
FBIO icon
5367
Fortress Biotech
FBIO
$92.7M
$95K ﹤0.01%
7,690
-9,535
-55% -$114K
INTR icon
5368
Inter&Co
INTR
$2.52B
$95K ﹤0.01%
55,604
-1,291,778
-96% -$2.7M
PLBY icon
5369
Playboy Inc
PLBY
$134M
$95K ﹤0.01%
47,874
-86,566
-64% -$215K
BRNS
5370
Barinthus Biotherapeutics
BRNS
$23.3M
$94K ﹤0.01%
41,945
+1,557
+4% +$4.33K
SCNI
5371
Scinai Immunotherapeutics
SCNI
$1.29M
$94K ﹤0.01%
+4,360
New +$108K
CISO
5372
CISO Global
CISO
$12.2M
$93K ﹤0.01%
+18,439
New +$300K
SKYH.WS icon
5373
CALL
Sky Harbour Group Warrants
SKYH.WS
$19.1M
$93K ﹤0.01%
190,555
VGZ icon
5374
Vista Gold
VGZ
$290M
$93K ﹤0.01%
+153,994
New +$86.9K
PFIE
5375
DELISTED
Profire Energy, Inc
PFIE
$93K ﹤0.01%
74,761
+14,216
+23% +$16.4K

Similar funds

Millennium Management's Q1 2023 Portfolio in Review

As of Q1 2023, Millennium Management held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Millennium Management withdrew a net $18.1B in Q1 2023, closing 1,209 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Millennium Management opened a new position in Warner Bros worth $96.9M.

  • Millennium Management's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
  • Millennium Management added most to Linde in Q1 2023, an estimated $374M increase.
  • Millennium Management's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
  • Millennium Management fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
  • Millennium Management's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
  • Millennium Management opened 987 new positions and closed 1,209 in Q1 2023.
  • Millennium Management's portfolio value fell 3.5% quarter-over-quarter to $174B.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.